Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Kamada Ltd (KMDA)

$5.92 0.04 (0.67%)

16:00 EST KMDA Stock Quote Delayed 15 Minutes

Volume:

Previous Close $5.92

Market Cap 215.60M

PE Ratio -

EPS -

Volume (Avg. Vol.) 105,900

Day's Range 5.90 - 6.10

52-Week Range 4.63 - 6.70

Dividend & Yield N/A (N/A)

KMDA Stock Predictions, Articles, and Kamada Ltd News

From InvestorPlace
From the Web

8 Undervalued Biotech Stocks to Watch

By Josh Enomoto, InvestorPlace Contributor Aug 20, 2018

Volatility across all categories of biotech stocks makes this present juncture an ideal time to consider picking up undervalued names.

4 Undervalued MedTech Stocks to Consider Amid Volatility

By Zacks Investment Research Jun 19, 2018

Amid turbulences of the U.S. market, some value stocks of MedTech industry appear to be lucrative investment options. Compare Brokers....

Kamada Ltd (KMDA) Q3 2019 Earnings Call Transcript

From The Motley Fool Nov 13, 2019

KMDA earnings call for the period ending September 30, 2019.

Kamada (KMDA) Shares Cross Above 200 DMA

From Market News Video Nov 13, 2019

In trading on Wednesday, shares of Kamada Ltd (KMDA) crossed above their 200 day moving average of $5.58, changing hands as high as $5.65 per share. Kamada Ltd shares are currently trading up about 1.8% on the day..

Kamada (KMDA) Beats Q3 Earnings and Revenue Estimates

From Zacks Investment Research Nov 13, 2019

Kamada (KMDA) delivered earnings and revenue surprises of 66.67% and 14.28%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Kamada (KMDA) to Report Q3 Results: Wall Street Expects Earnings Growth

From Zacks Investment Research Nov 4, 2019

Kamada (KMDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kamada extends GLASSIA supply and distribution agreement with Takeda

From Seeking Alpha Sep 3, 2019

Kamada (NASDAQ:KMDA) has extended its strategic supply agreement with Takeda for GLASSIA [Alpha1-Proteinase Inhibitor (Human)]. Kamada will now continue to produce GLASSIA for Takeda through 2021.Bas

Analysts Are Bullish on Top Healthcare Stocks: Novavax (NVAX), Kamada (KMDA)

From Smarter Analyst Aug 8, 2019

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novavax (NVAX) and Kamada (KMDA) with bullish sentiments.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!